Annual revenue was roughly flat at KRW 352.9 billion in 2022 and KRW 350.7 billion in 2023, before jumping to KRW 519.8 billion (+48.3%) in 2024 and KRW 578.0 billion (+11.2%) in 2025.
Operating profit rose steadily from KRW 14.1 billion in 2022 and KRW 16.1 billion in 2023 to KRW 26.1 billion in 2024 and KRW 28.7 billion in 2025, with operating margin improving from 4.0% to 4.6% to 5.0% to 5.0%.
Net income attributable to owners, however, moved in the opposite direction of the top line: it climbed from KRW 20.3 billion in 2022 to KRW 16.3 billion in 2023 and KRW 22.3 billion in 2024, but then fell sharply to KRW 8.5 billion in 2025.
Notably, total net income in 2025 (KRW 7.6 billion) was smaller than the owners' portion (KRW 8.5 billion), implying that non-controlling interests recorded a loss, which points to non-operating swings at the subsidiary level as the key driver of the annual net income volatility.
Quarterly data confirm this pattern: 2Q25 posted operating profit of KRW 12.2 billion but owners' net income of only KRW 0.12 billion, and 4Q25 similarly showed operating profit of KRW 7.0 billion against net income of just KRW 0.33 billion.
The picture changed in 1Q26 and 2Q26, when operating profit and net income improved together—1Q26 delivered KRW 13.5 billion in operating profit and KRW 11.9 billion in owners' net income, while 2Q26 posted KRW 27.3 billion and KRW 21.5 billion, respectively, marking the clearest improvement within the trailing four-quarter window (3Q25-2Q26).
Owners' net income across that four-quarter window totaled KRW 41.6 billion, well above the full-year 2025 figure of KRW 8.5 billion, driven largely by the recovery in the two most recent quarters.
Overall, the core plasma component business showed a gradual but directional recovery, while large swings in annual net income appear attributable mainly to non-operating items.